BrainCheck, a leading digital platform for cognitive assessment and care, has announced that Dr. Liz Kwo, MD, MBA, MPH, has joined its Board of Directors. The company highlighted her extensive expertise in clinical care, healthcare operations, digital health, and governance as a key asset for guiding BrainCheck’s growth and strategic initiatives.
Chris Loughlin, Chief Executive Officer of BrainCheck, stated that Dr. Kwo brings an exceptional blend of clinical insight, executive leadership, and board-level experience. He emphasized that her background in scaling digital health platforms and her experience across payer, provider, and technology environments will be invaluable as BrainCheck continues to expand its offerings and impact.
Health Technology Insights: MHK Launches SmartProminence AI Solutions
Dr. Kwo is a nationally recognized physician executive with deep experience in clinical operations, digital and population health, and governance for both public and private healthcare organizations. She is a Fulbright Scholar, an acknowledgment of her early contributions to healthcare systems and public health innovation. She earned a Bachelor of Arts in Human Biology from Stanford University, a Doctor of Medicine from Harvard Medical School, an MBA from Harvard Business School, and a Master of Public Health from the Harvard T.H. Chan School of Public Health with a focus on population health. She is board-certified in Preventive Medicine, with specialized training in occupational and environmental medicine, early disease detection, chronic disease management, and healthcare utilization.
Currently, Dr. Kwo serves as Chief Commercial Officer at Everly Health, where she leads a business exceeding $100 million, overseeing commercialization, clinical innovation, and the introduction of first-to-market diagnostic products. She previously held the position of Chief Medical Officer at Everly Health, managing clinical programs, telehealth strategy, quality oversight, and provider network development. Her earlier roles at Anthem, now Elevance Health, included Deputy Chief Clinical Officer and Staff Vice President of Clinical Data Analytics, where she modernized population health programs across commercial, Medicare, Medicaid, and employer populations, focusing on digital care management, cost control, and performance improvement.
Health Technology Insights: Artera Secures $65Million Growth Investment and Reaches $100Million CARR
In addition to her operational leadership, Dr. Kwo has founded, grown, and successfully exited healthcare technology ventures, including serving as CEO and Co-Founder of InfiniteMD, a medical second-opinion platform acquired by ConsumerMedical. She has held executive roles at Amwell, helping scale one of the nation’s first large-scale online medical groups, and brings experience in venture investment and medical device innovation.
Dr. Kwo also has extensive board experience, serving on public and private healthcare and technology company boards, including Kestra Medical Technologies, Walmart de México y Centroamérica, Asensus Surgical, and Mass General Brigham Innovation. She has chaired governance and nominating committees and completed advanced executive education in corporate governance, audit oversight, compensation committees, ESG materiality, and cybersecurity.
Dr. Kwo commented on her appointment, saying she is excited to join the BrainCheck Board at a pivotal time for cognitive care. She highlighted the importance of early detection, objective assessment, and scalable care models for addressing the growing impact of cognitive impairment. As a board member, she will contribute to BrainCheck’s strategic direction, partnerships, and efforts to modernize cognitive assessment and care across clinical and research settings.
Health Technology Insights: First Stop Health Joins ParetoHealth Network
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
